You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

daratumumab

( DAR a TOOM ue mab )
Funding:
New Drug Funding Program
  • Daratumumab – In Combination with Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma
  • Daratumumab – In Combination with Bortezomib and Dexamethasone for Relapsed Multiple Myeloma
Other Name(s): Darzalex®
Appearance: Clear, colourless to yellow solution, mixed into large bags of fluid

You might also be interested in